Interestingly, AREG stimulates the activation of the epithelial–mesenchymal transition (EMT) programme, downregulating epithelial cell marker expression and increasing the expression of mesenchymal markers; in this way, AREG drives the development of fibrotic disease and cancer invasion [35]. The gene discussed is AREG; the disease is cancer.